Stock listing

NASDAQ:MACK Merrimack Pharmaceuticals Inc Stock

Follow Merrimack Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MACK

$15.13 USD

Close on May 17, 2024 · No longer trades

Sep 6, 2017 to last close +28.4% · weekly closes, Sep 6, 2017 – May 17, 2024
Lowest – highest close
$1.63 – $15.13 USDSince Sep 6, 2017 · lowest Mar 20, 2020 · highest May 15, 2024

Delisted NASDAQ:MACK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MACK
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Merrimack Pharmaceuticals Inc on 6ix

Decks
2 decks · latest Jan 9, 2017

Decks

DeckKindSlidesDate
Merger or Acquisition (January 2017)Merger or acquisition26 slidesJan 9, 2017
Investor Presentation (September 2013)Investor deck21 slidesSep 9, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jean Franchi
Other companies: Disc Medicine, Inc. (Chief Financial Officer · Since at least Feb 7, 2024); Biodesix, Inc. (Director · Since at least Oct 27, 2020); Replimune Group, Inc. (Chief Financial Officer · Dec 9, 2019 – May 16, 2023 · Past)
Chief Financial Officer · Feb 15, 2018 – Dec 11, 2018 · Past
Richard Peters
Other companies: Kineta Inc. (Director · Since at least Dec 22, 2020); Aprea Therapeutics, Inc. (Director · Since at least Jun 26, 2020)
President and CEO, Director · May 8, 2019 – May 8, 2019 · Past
Noah G Levy
Other companies: Inflection Point Acquisition Corp. III (Director · Apr 24, 2025 – Apr 24, 2025 · Past)
Director · Dec 30, 2022 – Jan 12, 2023 · Past
Robert C Gay
Other companies: Angel Studios, Inc. (Director · Since at least Sep 10, 2025)
Director · Jan 31, 2012 – Apr 3, 2012 · Past
Sergio L Santillana
Other companies: ImageneBio, Inc. (Chief Medical Officer · Mar 25, 2021 – Jan 3, 2023 · Past)
Chief Medical Officer · Jun 12, 2017 – Dec 11, 2018 · Past
Clet M NiyikizaEVP of Development · Jan 31, 2012 – Mar 12, 2013 · Past
Daryl C DrummondHead of Research · Mar 31, 2017 – Dec 11, 2018 · Past
Edward J StewartHead of Commercial · Jul 15, 2015 – Jul 26, 2016 · Past
Gary L CrockerSee Remarks, Director · Jun 13, 2018 – Aug 10, 2023 · Past
John MendelsohnDirector · Jun 13, 2012 – Sep 13, 2017 · Past
All 13 people
PersonSeat
Thomas E Needham JrChief Business Officer · Jul 24, 2017 – Aug 1, 2017 · Past
Ulrik B NielsenDirector · Jun 10, 2021 – Jun 6, 2023 · Past
William M McClementsHead of Corporate Operations · Jan 31, 2012 – Feb 29, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Merrimack Pharmaceuticals Inc.